MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN
Abstract
The article deals with the long acting β2-agonists in therapy of children, suffering from the bronchial asthma, with regards to the recommendations of the modern manuals. Inhalant long acting β2-agonists, which formoterol and salmeterol belong to, are applied in combination with the inhalatory glucocorticosteroids among the patients with poor control asthma at inhalatory glucocorticosteroids based monotherapy.
Key words: long acting β2-agonists, formoterol, salmeterol, bronchial asthma, children.
Key words: long acting β2-agonists, formoterol, salmeterol, bronchial asthma, children.
About the Authors
Yu.G. Levina
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L.S. Namazova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Levina Yu., Namazova L. MODERN VIEW ON THE LONG ACTING β2-AGONISTS IN THERAPY FOR THE BRONCHIAL ASTHMA AMONG CHILDREN. Pediatric pharmacology. 2008;5(3):85-89.
Views:
743
Email this article 